Delayed
NSE India S.E.
09:27:50 13/05/2024 am IST
|
5-day change
|
1st Jan Change
|
56
INR
|
+0.36%
|
|
-8.79%
|
-16.73%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,253
|
620
|
207.9
|
440.4
|
504.2
|
921.8
|
Enterprise Value (EV)
1 |
1,734
|
1,055
|
543.4
|
792.9
|
931.1
|
1,200
|
P/E ratio
|
25.1
x
|
8.46
x
|
3.18
x
|
7.44
x
|
7.45
x
|
13.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.76
x
|
0.43
x
|
0.17
x
|
0.32
x
|
0.35
x
|
0.48
x
|
EV / Revenue
|
1.05
x
|
0.73
x
|
0.44
x
|
0.59
x
|
0.65
x
|
0.62
x
|
EV / EBITDA
|
11
x
|
5.67
x
|
4.36
x
|
4.56
x
|
5.62
x
|
9.22
x
|
EV / FCF
|
-
|
58,06,55,250
x
|
91,22,895
x
|
-11,19,80,283
x
|
-40,57,601
x
|
1,42,75,157
x
|
FCF Yield
|
-
|
0%
|
0%
|
-0%
|
-0%
|
0%
|
Price to Book
|
2.16
x
|
0.94
x
|
0.29
x
|
0.57
x
|
0.61
x
|
1.03
x
|
Nbr of stocks (in thousands)
|
18,236
|
18,236
|
18,236
|
18,236
|
18,236
|
18,236
|
Reference price
2 |
68.70
|
34.00
|
11.40
|
24.15
|
27.65
|
50.55
|
Announcement Date
|
17/08/18
|
06/09/19
|
29/06/20
|
26/08/21
|
13/09/22
|
06/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,648
|
1,447
|
1,244
|
1,355
|
1,436
|
1,920
|
EBITDA
1 |
157.1
|
186
|
124.8
|
173.9
|
165.8
|
130.1
|
EBIT
1 |
110.2
|
142.1
|
80.85
|
126
|
119.9
|
87.29
|
Operating Margin
|
6.69%
|
9.82%
|
6.5%
|
9.3%
|
8.35%
|
4.55%
|
Earnings before Tax (EBT)
1 |
71.87
|
102
|
77.23
|
82.83
|
87.01
|
106.2
|
Net income
1 |
49.94
|
73.26
|
65.28
|
59.18
|
67.67
|
67.83
|
Net margin
|
3.03%
|
5.06%
|
5.25%
|
4.37%
|
4.71%
|
3.53%
|
EPS
2 |
2.740
|
4.017
|
3.580
|
3.245
|
3.710
|
3.720
|
Free Cash Flow
|
-
|
1.817
|
59.56
|
-7.08
|
-229.5
|
84.04
|
FCF margin
|
-
|
0.13%
|
4.79%
|
-0.52%
|
-15.98%
|
4.38%
|
FCF Conversion (EBITDA)
|
-
|
0.98%
|
47.74%
|
-
|
-
|
64.6%
|
FCF Conversion (Net income)
|
-
|
2.48%
|
91.24%
|
-
|
-
|
123.89%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
17/08/18
|
06/09/19
|
29/06/20
|
26/08/21
|
13/09/22
|
06/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
481
|
435
|
335
|
352
|
427
|
278
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.061
x
|
2.339
x
|
2.689
x
|
2.026
x
|
2.574
x
|
2.136
x
|
Free Cash Flow
|
-
|
1.82
|
59.6
|
-7.08
|
-229
|
84
|
ROE (net income / shareholders' equity)
|
-
|
11.8%
|
9.46%
|
8.24%
|
8.76%
|
7.81%
|
ROA (Net income/ Total Assets)
|
-
|
6.55%
|
3.78%
|
5.62%
|
4.93%
|
3.69%
|
Assets
1 |
-
|
1,118
|
1,726
|
1,053
|
1,372
|
1,838
|
Book Value Per Share
2 |
31.80
|
36.10
|
39.60
|
42.50
|
45.70
|
49.20
|
Cash Flow per Share
2 |
1.320
|
0.4000
|
0.7500
|
0.5900
|
0.6000
|
0.1000
|
Capex
|
-
|
47.8
|
28.2
|
77.4
|
135
|
29
|
Capex / Sales
|
-
|
3.3%
|
2.27%
|
5.71%
|
9.42%
|
1.51%
|
Announcement Date
|
17/08/18
|
06/09/19
|
29/06/20
|
26/08/21
|
13/09/22
|
06/09/23
|
|
1st Jan change
|
Capi.
|
---|
| -16.73% | 12.18M | | +9.72% | 27.43B | | -29.70% | 3.18B | | -16.08% | 2.53B | | +19.05% | 2.49B | | +11.11% | 2.16B | | -4.24% | 2.03B | | +5.56% | 1.61B | | +3.25% | 1.31B | | +29.73% | 1.29B |
Medical Supplies
|